CollPlant Biotechnologies (CLGN) Non Operating Income (2018 - 2025)
CollPlant Biotechnologies (CLGN) reported Non Operating Income of -$57000.0 for Q4 2025, down 159.38% on a YoY basis from $96000.0 in Q4 2024, and down 337.5% quarter-over-quarter from $24000.0 in Q3 2025.
CollPlant Biotechnologies (CLGN) Non Operating Income (2018 - 2025) Analysis & Trends
CollPlant Biotechnologies has reported Non Operating Income for 8 years, with the latest figure at -$57000.0 in Q4 2025.
- For the quarter ending Q4 2025, Non Operating Income fell 159.38% year-over-year to -$57000.0; the trailing twelve-month figure through Dec 2025 stood at -$6000.0 (down 100.93% YoY), and the FY2025 full-year result was -$6000.0, down 100.93% from the prior year.
- Non Operating Income for Q4 2025 stood at -$57000.0, down from $24000.0 in the prior quarter.
- The five-year high for Non Operating Income was $379000.0 in Q4 2023, with the low at -$196000.0 in Q1 2023.
- Historically, Non Operating Income has averaged $73650.0 across 5 years, with a median of $87000.0 in 2022.
- The largest YoY upside for Non Operating Income was 759.38% in 2022 against a maximum downside of 500.0% in 2022.
- CollPlant Biotechnologies' Non Operating Income stood at $32000.0 in 2021, then surged by 759.38% to $275000.0 in 2022, then surged by 37.82% to $379000.0 in 2023, then slumped by 74.67% to $96000.0 in 2024, then sank by 159.38% to -$57000.0 in 2025.
- The last three Non Operating Income figures came in at -$57000.0 (Q4 2025), $24000.0 (Q3 2025), and -$169000.0 (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 5.75 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 444,000.00 |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | - |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | 9.35 Mn |
| 10 | CollPlant Biotechnologies | 7.20 Mn | 7.20 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -57,000.00 |
| Sep 30, 2025 | 24,000.00 |
| Jun 30, 2025 | -169,000.00 |
| Mar 31, 2025 | 196,000.00 |
| Dec 31, 2024 | 96,000.00 |
| Sep 30, 2024 | 216,000.00 |
| Jun 30, 2024 | 196,000.00 |
| Mar 31, 2024 | 134,000.00 |
| Dec 31, 2023 | 379,000.00 |
| Sep 30, 2023 | 225,000.00 |
| Jun 30, 2023 | 85,000.00 |
| Mar 31, 2023 | -196,000.00 |
| Dec 31, 2022 | 275,000.00 |
| Sep 30, 2022 | 89,000.00 |
| Jun 30, 2022 | -100,000.00 |
| Mar 31, 2022 | -92,000.00 |
| Dec 31, 2021 | 32,000.00 |
| Sep 30, 2021 | 17,000.00 |
| Jun 30, 2021 | 25,000.00 |
| Mar 31, 2021 | 98,000.00 |